MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Evaluating the Accuracy of an Integrated Vital Sign Measurement Platform

Not Applicable

Completed

Conditions: Multimorbidity

Interventions: Other: Vital Moto Mod
Other: Welch Allyn Connex Spot Vital Signs Monitor
Other: Capnostream 20 Portable Bedside Capnograph
Other: Welch Allyn 767 Mobile Aneroid Sphygmomanometerand 3M Littmann Master Classic II Teaching Stethoscope
Other: Scifit 1000R cycle ergometer

First Posted Date: 2018-07-18

Last Posted Date: 2020-09-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 265

Registration Number: NCT03589716

Locations: 🇺🇸
Partners Connected Health, Boston, Massachusetts, United States

Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis

Not yet recruiting

Conditions: Stevens-Johnson Syndrome
Toxic Epidermal Necrolysis
Drug Reaction

Interventions: Drug: Site specific standard of care comparison

First Posted Date: 2018-07-13

Last Posted Date: 2023-04-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 750

Registration Number: NCT03585946

Phase II Clinical Trial: Multi-dosing the BCG Vaccine for Fibromyalgia

Phase 2

Withdrawn

Conditions: Fibromyalgia

Interventions: Biological: Bacillus Calmette Guerin Vaccine
Biological: Saline Injection

First Posted Date: 2018-07-10

Last Posted Date: 2024-11-21

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT03582085

Locations: 🇺🇸
Immunobiology Labs CNY 149, Charlestown, Massachusetts, United States

Stress Management and Resiliency Training for Physicians

Not Applicable

Conditions: Burnout, Professional
Stress

Interventions: Behavioral: SMART-3RP

First Posted Date: 2018-06-27

Last Posted Date: 2021-02-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 160

Registration Number: NCT03570853

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Newton Wellesley Hospital, Newton, Massachusetts, United States

Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy

Not Applicable

Active, not recruiting

Conditions: Gastrointestinal Disease

Interventions: Device: Cryobiopsy probe, administered to study participants

First Posted Date: 2018-06-25

Last Posted Date: 2024-05-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT03566160

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

IDH1 Inhibition Using Ivosidenib as Maintenance Therapy for IDH1-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation

Phase 1

Completed

Conditions: IDH1 Mutation Myeloid Neoplasms

Interventions: Drug: Ivosidenib

First Posted Date: 2018-06-21

Last Posted Date: 2024-03-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 18

Registration Number: NCT03564821

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸
Johns Hopkins Cancer Center, Baltimore, Maryland, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

and more 1 locations

The Insulin-Only Bionic Pancreas Bridging Study

Phase 2

Completed

Conditions: Type1 Diabetes Mellitus

Interventions: Device: iLet Bionic Pancreas insulin-only configuration with Humalog or Novolog
Drug: iLet Bionic Pancreas insulin-only configuration with Fiasp
Other: Usual care

First Posted Date: 2018-06-21

Last Posted Date: 2019-09-04

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 36

Registration Number: NCT03565666

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States
🇺🇸
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, United States
🇺🇸
Nemours Children's Specialty Care, Jacksonville, Florida, United States

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Phase 2

Active, not recruiting

Conditions: Pancreatic Cancer

Interventions: Drug: FOLFIRINOX
Radiation: SBRT
Drug: Losartan
Procedure: Surgery
Drug: Nivolumab

First Posted Date: 2018-06-20

Last Posted Date: 2022-09-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 168

Registration Number: NCT03563248

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Sibley Memorial Hospital, Washington, District of Columbia, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 7 locations

Golf Instruction Versus Tai Chi for People With Parkinson's Disease

Not Applicable

Completed

Conditions: Neuro-Degenerative Disease
Movement Disorders
Parkinson Disease

Interventions: Other: Golf Instruction
Other: Tai Chi Class

First Posted Date: 2018-06-20

Last Posted Date: 2020-09-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 35

Registration Number: NCT03563807

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Randomized Controlled Trial of an Advanced Care Planning Video Decision Support Tool for Patients With End-Stage Liver Disease

Not Applicable

Completed

Conditions: End Stage Liver Disease

Interventions: Behavioral: Advance Care Planning Video Decision Support Tool
Other: Verbal Narrative

First Posted Date: 2018-06-14

Last Posted Date: 2024-03-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT03557086

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy